Product NDC: | 55390-412 |
Proprietary Name: | Haloperidol decanoate |
Non Proprietary Name: | Haloperidol decanoate |
Active Ingredient(s): | 70.52 mg/mL & nbsp; Haloperidol decanoate |
Administration Route(s): | INTRAMUSCULAR |
Dosage Form(s): | INJECTION |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 55390-412 |
Labeler Name: | Bedford Laboratories |
Product Type: | HUMAN PRESCRIPTION DRUG |
FDA Application Number: | ANDA074811 |
Marketing Category: | ANDA |
Start Marketing Date: | 19980217 |
Package NDC: | 55390-412-01 |
Package Description: | 10 VIAL in 1 BOX (55390-412-01) > 1 mL in 1 VIAL |
NDC Code | 55390-412-01 |
Proprietary Name | Haloperidol decanoate |
Package Description | 10 VIAL in 1 BOX (55390-412-01) > 1 mL in 1 VIAL |
Product NDC | 55390-412 |
Product Type Name | HUMAN PRESCRIPTION DRUG |
Non Proprietary Name | Haloperidol decanoate |
Dosage Form Name | INJECTION |
Route Name | INTRAMUSCULAR |
Start Marketing Date | 19980217 |
Marketing Category Name | ANDA |
Labeler Name | Bedford Laboratories |
Substance Name | HALOPERIDOL DECANOATE |
Strength Number | 70.52 |
Strength Unit | mg/mL |
Pharmaceutical Classes | Typical Antipsychotic [EPC] |